Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Response Evaluation”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Not applicableStudy completedNCT05648929
What this trial is testing

Experimental and Clinical Investigation of the Implant Surface Roughness Reduction Effect on Early-stage Fibrosis

Who this might be right for
Capsular Contracture Associated With ImplantForeign-Body ReactionWounds and Injuries+1 more
Medical University Innsbruck 14
Not applicableStudy completedNCT01650077
What this trial is testing

Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria

Who this might be right for
Soft Tissue Sarcoma
Centre Oscar Lambret 134
Post-approval studies (Phase 4)Looking for participantsNCT05685940
What this trial is testing

Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 100
Large-scale testing (Phase 3)Ended earlyNCT01981707
What this trial is testing

F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer

Who this might be right for
Castration-resistant Prostate Cancer
University Hospital, Grenoble 12
Post-approval studies (Phase 4)UnknownNCT01835613
What this trial is testing

Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.

Who this might be right for
Rheumatoid Arthritis (RA)
Osservatorio Epidemiologico GISEA 150
Not applicableLooking for participantsNCT06550427
What this trial is testing

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

Who this might be right for
LymphomaHodgkin LymphomaT-cell Lymphoma+1 more
National Taiwan University Hospital 200
Not applicableStudy completedNCT01269970
What this trial is testing

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Who this might be right for
Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
Universitaire Ziekenhuizen KU Leuven
Large-scale testing (Phase 3)Study completedNCT00558883
What this trial is testing

AI(I)DA Acarbose and the Subclinical Inflammation

Who this might be right for
Type 2 Diabetes MellitusSubclinical Inflammation
GWT-TUD GmbH 104
Not applicableLooking for participantsNCT02613988
What this trial is testing

Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas

Who this might be right for
Adult Glioblastoma
Asan Medical Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Not applicableLooking for participantsNCT04134780
What this trial is testing

Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 150
Testing effectiveness (Phase 2)Study completedNCT00963807
What this trial is testing

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)UnknownNCT04062656
What this trial is testing

Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG

Who this might be right for
Gastric CancerAdenocarcinoma of the Esophagogastric Junction
University Hospital, Essen 21
Testing effectiveness (Phase 2)Study completedNCT00748306
What this trial is testing

Study in Mild Asthmatic Patients

Who this might be right for
Asthma
GlaxoSmithKline 19
Not applicableStudy completedNCT02915861
What this trial is testing

Eschar Investigations in Scrub Typhus

Who this might be right for
Scrub Typhus
University of Oxford 44
Not applicableStudy completedNCT00748241
What this trial is testing

Study to Evaluate Implant Survival Rate of Astra Tech Fixture ST in the Posterior Maxilla With One-stage Surgery and Early Loading

Who this might be right for
Jaw, Edentulous, Partially
Dentsply Sirona Implants and Consumables 19
Not applicableStudy completedNCT04341662
What this trial is testing

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

Who this might be right for
Post-Partum Haemorrhage
University of Birmingham 99,659
Not applicableStudy completedNCT03215394
What this trial is testing

Evaluation of Social ABCs With Attention Training Intervention for Toddlers With Suspected Autism

Who this might be right for
Autism Spectrum Disorder
Holland Bloorview Kids Rehabilitation Hospital 150
Early research (Phase 1)WithdrawnNCT05774886
What this trial is testing

Implantable Microdevice for TNBC - Pilot Study

Who this might be right for
Triple Negative Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+4 more
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00636441
What this trial is testing

Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer

Who this might be right for
Early-Stage Breast Cancer
Duke University 56
Load More Results